美女免费一级视频在线观看

    1. <form id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></form>
      <address id=BiMYPaeIF><nobr id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></nobr></address>

      Backed by Johnson & Johnson and Arcutis Biotherapeutics, the Skin of Color Society (SOCS) released the first in a series of educational videos addressing skincare conditions impacting patients of color on Monday.

      Derived from the content featured at the 2024 SOCS Media Day held in March, the videos were released in two segments: Ask the Experts and MelanantED. 

      Both series serve educational purposes for patients, physicians and the general public about dermatologic conditions which affect people of color. 

      The Ask the Expert series features SOCS experts as they explore different topics ranging from psoriasis, seborrheic dermatitis, aging, skincare routines and sunscreen usage.  

      Meanwhile, MelanatED represents an augmentation of the existing series from last year, exploring topics like hair styling, acne on skin of color and social media misinformation. 

      In addition to J&J and Arcutis, the videos are also sponsored by Procter & Gamble, Clinique, and EltaMD.

      This newest release keeps with the SOCS mission to increase diversity in dermatology and train dermatologists to give culturally competent care. It also bolsters ongoing health equity efforts led by SOCS through digital media channels. 

      “We are thrilled to share these insightful videos as part of our deep commitment to educating our patients, fellow physicians and the public,” SOCS President Dr. Victoria Barbosa said in a statement. “As dermatologists and SOCS members, we are passionate about promoting excellence in patient care and achieving health equity for all.”

      This video series release marks the first of many, as SOCS announced it will publish more educational clips throughout the year. 

      For J&J, sponsoring this series comes a few months after the pharma giant announced partnerships with more than 100 different organizations dedicated to eliminating disparities for BIPOC patients across the country. 

      More recently, J&J released data that showed its psoriasis drug, Tremyfa, is safe and effective for patients of all skin tones. 

      As for Acrutis, the drugmaker launched a campaign focused on seborrheic dermatitis at the end of 2023. The campaign included testimonials from patients of color as well as educational information as to how the disease presents itself on darker skin tones. 

      These companies are not alone in this effort, as the mission of health equity in skincare echoes across the pharmaceutical industry.

      Just recently, Eli Lilly launched the latest edition of its Get Better campaign with an emphasis on skin and health disparities experienced by patients of color. 

      To read a March 2025 article on Arcutis throwing to Odell Beckham Jr. as the latest face of Zorvye foam, click here.